Cubist Systematic Strategies’s Atara Biotherapeutics ATRA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-12,682
| Closed | -$169K | – | 1468 |
|
2024
Q4 | $169K | Buy |
+12,682
| New | +$169K | ﹤0.01% | 1214 |
|
2024
Q3 | – | Sell |
-9,271
| Closed | -$78.8K | – | 1493 |
|
2024
Q2 | $78.8K | Buy |
+9,271
| New | +$78.8K | ﹤0.01% | 1198 |
|
2024
Q1 | – | Sell |
-1,458
| Closed | -$18.7K | – | 2221 |
|
2023
Q4 | $18.7K | Sell |
1,458
-320
| -18% | -$4.1K | ﹤0.01% | 1941 |
|
2023
Q3 | $65.8K | Sell |
1,778
-9,285
| -84% | -$343K | ﹤0.01% | 1681 |
|
2023
Q2 | $445K | Buy |
11,063
+2,889
| +35% | +$116K | ﹤0.01% | 1448 |
|
2023
Q1 | $593K | Buy |
8,174
+916
| +13% | +$66.4K | ﹤0.01% | 1732 |
|
2022
Q4 | $595K | Buy |
7,258
+6,239
| +612% | +$512K | ﹤0.01% | 2088 |
|
2022
Q3 | $96K | Sell |
1,019
-9
| -0.9% | -$848 | ﹤0.01% | 3229 |
|
2022
Q2 | $200K | Sell |
1,028
-1,778
| -63% | -$346K | ﹤0.01% | 3168 |
|
2022
Q1 | $652K | Buy |
2,806
+2,053
| +273% | +$477K | 0.01% | 2352 |
|
2021
Q4 | $297K | Buy |
753
+51
| +7% | +$20.1K | ﹤0.01% | 2805 |
|
2021
Q3 | $314K | Sell |
702
-792
| -53% | -$354K | ﹤0.01% | 2328 |
|
2021
Q2 | $581K | Sell |
1,494
-2,644
| -64% | -$1.03M | 0.01% | 1909 |
|
2021
Q1 | $1.49M | Buy |
4,138
+1,841
| +80% | +$661K | 0.02% | 1256 |
|
2020
Q4 | $1.13M | Buy |
2,297
+1,780
| +344% | +$873K | 0.02% | 1310 |
|
2020
Q3 | $167K | Buy |
517
+260
| +101% | +$84K | ﹤0.01% | 2178 |
|
2020
Q2 | $94K | Sell |
257
-1,301
| -84% | -$476K | ﹤0.01% | 2203 |
|
2020
Q1 | $331K | Buy |
+1,558
| New | +$331K | 0.01% | 1465 |
|
2019
Q4 | – | Sell |
-2,510
| Closed | -$886K | – | 2408 |
|
2019
Q3 | $886K | Buy |
2,510
+695
| +38% | +$245K | 0.02% | 1033 |
|
2019
Q2 | $912K | Buy |
+1,815
| New | +$912K | 0.02% | 1100 |
|
2019
Q1 | – | Sell |
-53
| Closed | -$46K | – | 2238 |
|
2018
Q4 | $46K | Buy |
+53
| New | +$46K | ﹤0.01% | 1878 |
|
2015
Q2 | – | Sell |
-69
| Closed | -$71K | – | 1817 |
|
2015
Q1 | $71K | Sell |
69
-345
| -83% | -$355K | ﹤0.01% | 1711 |
|
2014
Q4 | $277K | Buy |
+414
| New | +$277K | 0.02% | 1277 |
|